Intro to the multi-billion dollar Yaz birth control lawsuit
Women have sued, and Bayer Pharmaceuticals has lost — to the tune of $2 billion. The damages are real. So is the compensation.
Yaz birth control has been made and distributed by Bayer — one of the largest pharmaceutical companies in the world — since 2006. Despite its popularity in controlling many health issues, it has also come under fire for causing severe health complications in thousands of lawsuits. This article will discuss why the birth control pill Yaz, despite being able to treat and control multiple health concerns, also puts consumers at a higher risk of dangerous health complications — and will further explore the current state of the Yaz lawsuits currently taking place in the U.S.
What is drospirenone?
The hormone drospirenone is the active ingredient in Yaz, which allows it to be effective as a birth control pill, an acne treatment for moderate acne, and even to regulate and decrease the effects of premenstrual dysphoric disorder, otherwise known as PMDD. Drospirenone is a steroidal progestin — a synthetic progesterone — that prevents sperm from fertilizing eggs in the uterus, thus preventing pregnancy.
Beyond contraception, Yaz has also been used as a hormone replacement drug for women undergoing menopause, and to control moderate acne. Yaz is approved for use in individuals as young as 14 years old who have started their period. Drospirenone is also the active ingredient in two birth controls often associated with Yaz: Yasmin, developed and distributed by Bayer since 2001, and Ocella, the generic brand from Teva Pharmaceuticals, manufactured by Barr Laboratories, and available since 2002.
Overall, the health complications that many patients have reported after taking Yaz, Yasmin, or Ocella are directly connected to the synthetic progesterone, drospirenone, found in each pill.
Why are people filing lawsuits against Yaz?
In July of 2015, Bayer reported to investors that it has paid $1.97 billion to approximately 9,900 women, averaging $200k per case. Then, in August 2015, Bayer agreed to pay another $56.9 million to 3,400 claimants for arterial thromboembolic injuries (mostly heart attack and stroke). Many of these cases concern the same issue: “arterial thromboembolic injuries” — which are most easily described as blood clots.
The FDA has stated that drospirenone may increase blood clot risks by 3 times. And that possibility seems to come to life in the thousands of lawsuits that have been filed against Yaz — wherein patients describe the side effects of blood clots, arterial blood clots, deep vein thrombosis, heart attack, and stroke.
One of the main claims against Yaz is that proper consumer awareness was not created by its marketing, leading to misunderstanding in the marketplace. When it was first introduced, many consumers had the impression that Yaz could treat any level of acne — from mild to severe — when Yaz should only be used to treat moderate acne. Relatedly, many consumers thought that Yaz could be prescribed to alleviate PMS symptoms, when it more accurately diminishes the more severe effects of PMDD.
How to file your own claim
If you or a loved one has suffered from the side effects of Yaz, or if your loved one has died after taking Yaz, Yasmin, or Ocella, you may be entitled to legal representation. Find out more about how to file your own claim by calling [XXX-XXX-XXXX].